High Quality Dienogestrel CAS 65928-58-7 Powder Fast Shipping Good Price
TDS
65928-58-7
Pharmaceutical Grade
99.5%
Hangzhou
HyperChem
1kg/Bag
2025-01-24
Pharmaceuticals,Peptide,Cosmetics,Nutritional Supplements
-
Product Description
-
Seller Information
-
DescriptionECHEMI Editorial ReferenceDienogest(STS-557) is a specific progesterone receptor agonist with potent oral endometrial activity and is used in the treatment of endometriosis. Target: progesterone receptor agonistDienogest is an orally active synthetic progesterone (or progestin). It is available for use as an oral contraceptive in combination with ethinylestradiol. It has antiandrogenic activity and as a result can improve androgenic symptoms. It is a non-ethinylated progestin which is structurally related to test
Dienogest is a steroid hormone that is 17beta-hydroxy-3-oxoestra-4,9-diene substituted at position 17 by a cyanomethyl group. Used as an oral contraceptive. It has a role as a synthetic oral contraceptive, a progesterone receptor agonist and a progestin. It is a 17beta-hydroxy steroid, a 3-oxo-Delta(4) steroid, a steroid hormone and an aliphatic nitrile. It derives from a hydride of an estrane.|Dienogest is an orally-active semisynthetic progestogen which also possesses the properties of 17α-hydroxyprogesterone. It is a derivative of 19-nortestosterone and has antiandrogenic properties. It is primarily used as a contraceptive in combination with ethinylestradiol, or in other combination form pills approved in United States and Europe however it is not available in the US by itself. In Europe, Australia, Malaysia, Singapore and Japan, dienogest single therapy is an approved treatment for endometriosis to alleviate painful symptoms of endometriosis and reduce endometriotic lesions. Dienogest is commonly marketed as Visanne, Natazia and Qlaira.|Dienogest is a Progestin.|Dienogest is an orally-active, semisynthetic, fourth generation, nonethinylated progestogen with antiproliferative, antiandrogenic, anti-inflammatory and antiangiogenic activities that is used in hormone therapy and as a female contraceptive. Upon oral administration, dienogest binds intracellular progesterone receptors which then translocate to the nucleus where the drug-receptor complex interacts with progesterone response elements, thus altering the expression of target genes. Dienogest reduces the production of estradiol, prevents ovulation and alters the cervical mucus and endometrium. In addition, dienogest appears to suppress the expression of cell cycle regulator cyclin D1. Altogether, this may prevent the growth of endometrial epithelial cells and may reduce symptoms associated with leiomyoma.CertificatesBasic Info-
Product Name:
Dienogest
Other Name:19-Norpregna-4,9-diene-21-nitrile,17-hydroxy-3-oxo-,(17α)-;(17α)-17-Hydroxy-3-oxo-19-norpregna-4,9-diene-21-nitrile;STS 557;Dienogest;Dienogestril;17α-Cyanomethyl-17β-hydroxyestra-4,9-dien-3-one;Dinagest
CAS No.:65928-58-7
Molecular Formula:C20H25NO2
InChIKeys:InChIKey=AZFLJNIPTRTECV-FUMNGEBKSA-N
Molecular Weight:311.422
Exact Mass:311.42
EC Number:1312995-182-4
UNII:46M3EV8HHE
NCI Thesaurus Code:C87238
ATC Code:G03DB08|G - Genito urinary system and sex hormones
Categories:
Characteristics-
PSA:
61.1
XLogP3:1.96
Appearance:Pale Yellow Solid
Density:1.2±0.1 g/cm3
Melting Point:210-2140C
Boiling Point:549.0±50.0 °C at 760 mmHg
Flash Point:285.8±30.1 °C
Refractive Index:1.589
Water Solubility:Practically insoluble in water
Storage Conditions:-20°C Freezer
Toxicity:LD50 oral in mouse: 4gm/kg
Specific rotation:D25 -290° (c = 0.5 in pyridine)
Hazard IdentificationClassification of the substance or mixture
Carcinogenicity, Category 2
Reproductive toxicity, Category 1A
Reproductive toxicity, Additional category for effects on or via lactation
GHS label elements, including precautionary statements
Pictogram(s)
Signal word Danger
Hazard statement(s) H351 Suspected of causing cancer
H360 May damage fertility or the unborn child
H362 May cause harm to breast-fed children
Precautionary statement(s) Prevention P203 Obtain, read and follow all safety instructions before use.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P260 Do not breathe dust/fume/gas/mist/vapours/spray.
P263 Avoid contact during pregnancy and while nursing.
P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
Response P318 IF exposed or concerned, get medical advice.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Pharmaceuticals,Peptide,Cosmetics,Nutritional Supplements
-
Location:
Rm. 803, Tower 4, LOFT49 Creative City Pioneer Zone, No.88 Jiru Rd. Gongshu Dist., Hangzhou, 310015 ZJ, China
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
10
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
11-50
-
Year of Establishment:
2013
-
Certifications:
Certification Report by Bureau Veritas
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
